Within a year, participants regained about two-thirds of the weight they had lost, and said goodbye to some of the improvements in blood pressure, blood sugar and cholesterol they had achieved, according to the landmark STEP 1 extension trial
When patients lose significant weight on incretin-based therapiesoften 10-15% or more of initial body weight in clinical trials such as the STEP program (semaglutide) and SURMOUNT trials (tirzepatide)the reduction in subcutaneous fat decreases the body's natural insulation layer, making environmental temperatures feel colder than before
Celebrating milestones boosts motivation in ways that just pushing harder cannot
At Neuvo Medical Spa, we provide ongoing support and monitoring to ensure that your weight loss journey stays on track
Although these drugs demonstrated effectiveness in improving blood sugar control and promoting weight loss, lawsuits now allege that GLP-1 receptor agonists may also be associated with severe gastrointestinal injuries, optic nerve complications, and other serious adverse health effects
